Treace Medical Concepts Inc (NAS:TMCI)
$ 8.55 -0.23 (-2.62%) Market Cap: 532.64 Mil Enterprise Value: 534.29 Mil PE Ratio: 0 PB Ratio: 5.06 GF Score: 40/100

Q1 2023 Treace Medical Concepts Inc Earnings Call Transcript

May 08, 2023 / 08:30PM GMT
Release Date Price: $25.97 (-1.89%)
Operator

Good day, and thank you for standing by. Welcome to the Treace Medical First Quarter 2023 Earnings Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker, Vivian Cervantes, Investor Relations at Gilmartin Group. Please go ahead.

Vivian Cervantes

Thanks, Teresa. Good afternoon, everyone, and welcome to our first quarter 2023 earnings conference call. Participating from the company today will be John Treace, Chief Executive Officer; and Mark Hair, Chief Financial Officer.

During the call, we will offer commentary on our commercial activity and review our first quarter financial results released after the close of the market today, after which we will host a question-and-answer session. The press release and supplemental materials can be found in the Investor Relations section of our website at investors.treace.com. This call is being recorded, and will be archived in the Investors section of our website.

Before we begin, we would like to remind

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot